You just read:

Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Acceptance for Review of the New Drug Submission of eslicarbazepine acetate as a Once-Daily Adjunctive Therapy for Partial-onset Seizures in Adults with Epilepsy

News provided by

Sunovion Pharmaceuticals Canada Inc.

Sep 18, 2013, 09:00 ET